(VIAV) Viavi Solutions - Ratings and Ratios
Network Test, Monitoring Assurance, Optical Coatings, Anti-Counterfeit
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 41.7% |
| Value at Risk 5%th | 56.9% |
| Relative Tail Risk | -17.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.40 |
| Alpha | 59.25 |
| CAGR/Max DD | 0.47 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.643 |
| Beta | 0.845 |
| Beta Downside | 1.163 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.88% |
| Mean DD | 17.43% |
| Median DD | 16.21% |
Description: VIAV Viavi Solutions November 10, 2025
Viavi Solutions Inc. (NASDAQ: VIAV) develops and sells network test, monitoring, and assurance hardware and software for a broad set of customers-including telecom operators, cloud providers, enterprises, first-responders, military, aerospace, and critical-infrastructure entities-across the Americas, APAC, Europe, the Middle East, and Africa.
The business is split into two operating segments. The Network and Service Enablement (NSE) segment delivers lab- and production-environment tools, AIOps platforms, and perpetual software licenses that support network design, deployment, performance monitoring, and security for wireless, wireline, satellite, and cloud networks. The Optical Security and Performance Products (OSP) segment leverages Viavi’s optical-coating expertise to produce anti-counterfeiting, 3-D sensing, and high-precision optical components for government, aerospace, automotive, and industrial markets.
In FY 2023 Viavi reported revenue of roughly $1.03 billion, up about 5 % YoY, with the NSE segment contributing ~70 % of sales and maintaining an operating margin near 12 %. The company’s growth is being driven by continued 5G roll-outs and increased telecom capex (global telecom equipment spending is forecast to expand ~3 % CAGR through 2029), as well as rising demand for OSP anti-counterfeiting solutions in the pharmaceutical and electronics supply chains.
For a deeper dive into Viavi’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich overview worth checking out.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (15.2m TTM) > 0 and > 6% of Revenue (6% = 68.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 43.03% (prev 63.71%; Δ -20.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 107.3m > Net Income 15.2m (YES >=105%, WARN >=100%) |
| Net Debt (247.8m) to EBITDA (125.7m) ratio: 1.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (222.9m) change vs 12m ago 0.41% (target <= -2.0% for YES) |
| Gross Margin 56.65% (prev 56.78%; Δ -0.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.96% (prev 57.02%; Δ 2.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.97 (EBITDA TTM 125.7m / Interest Expense TTM 29.9m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 46.05
| 1. Piotroski 4.0pt |
| 2. FCF Yield 1.89% |
| 3. FCF Margin 6.84% |
| 4. Debt/Equity 1.09 |
| 5. Debt/Ebitda 1.97 |
| 6. ROIC - WACC (= -1.92)% |
| 7. RoE 2.09% |
| 8. Rev. Trend -40.11% |
| 9. EPS Trend -47.14% |
What is the price of VIAV shares?
Over the past week, the price has changed by +4.03%, over one month by +2.86%, over three months by +57.80% and over the past year by +74.64%.
Is VIAV a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the VIAV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.4 | 0.6% |
| Analysts Target Price | 18.4 | 0.6% |
| ValueRay Target Price | 19.9 | 8.8% |
VIAV Fundamental Data Overview December 06, 2025
P/E Trailing = 291.6667
P/E Forward = 24.0385
P/S = 3.4107
P/B = 5.3988
P/EG = 2.41
Beta = 0.966
Revenue TTM = 1.15b USD
EBIT TTM = 58.9m USD
EBITDA TTM = 125.7m USD
Long Term Debt = 640.5m USD (from longTermDebt, last quarter)
Short Term Debt = 151.1m USD (from shortTermDebt, last quarter)
Debt = 791.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 247.8m USD (from netDebt column, last quarter)
Enterprise Value = 4.15b USD (3.91b + Debt 791.6m - CCE 545.6m)
Interest Coverage Ratio = 1.97 (Ebit TTM 58.9m / Interest Expense TTM 29.9m)
FCF Yield = 1.89% (FCF TTM 78.3m / Enterprise Value 4.15b)
FCF Margin = 6.84% (FCF TTM 78.3m / Revenue TTM 1.15b)
Net Margin = 1.33% (Net Income TTM 15.2m / Revenue TTM 1.15b)
Gross Margin = 56.65% ((Revenue TTM 1.15b - Cost of Revenue TTM 496.4m) / Revenue TTM)
Gross Margin QoQ = 56.00% (prev 55.77%)
Tobins Q-Ratio = 1.99 (Enterprise Value 4.15b / Total Assets 2.08b)
Interest Expense / Debt = 0.93% (Interest Expense 7.40m / Debt 791.6m)
Taxrate = -791.7% (out of range, set to none) (19.0m / -2.40m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.99 (Total Current Assets 990.3m / Total Current Liabilities 497.5m)
Debt / Equity = 1.09 (Debt 791.6m / totalStockholderEquity, last quarter 723.9m)
Debt / EBITDA = 1.97 (Net Debt 247.8m / EBITDA 125.7m)
Debt / FCF = 3.16 (Net Debt 247.8m / FCF TTM 78.3m)
Total Stockholder Equity = 728.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.73% (Net Income 15.2m / Total Assets 2.08b)
RoE = 2.09% (Net Income TTM 15.2m / Total Stockholder Equity 728.9m)
RoCE = 4.30% (EBIT 58.9m / Capital Employed (Equity 728.9m + L.T.Debt 640.5m))
RoIC = 5.67% (EBIT 58.9m / (Assets 2.08b - Curr.Liab 497.5m - Cash 545.6m))
WACC = 7.59% (E(3.91b)/V(4.70b) * Re(9.13%) + (debt cost/tax rate unavailable))
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.13%
[DCF Debug] Terminal Value 72.72% ; FCFE base≈70.8m ; Y1≈64.3m ; Y5≈56.2m
Fair Price DCF = 3.76 (DCF Value 838.7m / Shares Outstanding 223.2m; 5y FCF grow -11.48% → 3.0% )
EPS Correlation: -47.14 | EPS CAGR: -11.78% | SUE: 1.25 | # QB: 1
Revenue Correlation: -40.11 | Revenue CAGR: -1.35% | SUE: 1.02 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=+0.014 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-06-30): EPS=0.67 | Chg30d=+0.082 | Revisions Net=+7 | Growth EPS=+43.3% | Growth Revenue=+27.8%
EPS next Year (2027-06-30): EPS=0.83 | Chg30d=+0.165 | Revisions Net=+6 | Growth EPS=+23.7% | Growth Revenue=+8.8%
Additional Sources for VIAV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle